The blood plasma company Diag Human which is suing the Czech state for allegedly failing to protect its investment in the Czech Republic says the protracted court battle is not over. The company said on Monday it would appeal the verdict of a Czech arbitration court and take the case to a foreign court of law. The verdict of the arbitration court, delivered to both parties last week, is being interpreted differently. The Czech Health Ministry says it is a definitive verdict in the Czech Republic’s favour, meaning that following an appeal it will not have to pay the company eight billion crowns in compensation, while Diag Human claims that last week’s ruling upholds an earlier verdict according to which the Czech state will have to compensate the firm for a marred deal in the 1990s.
Prague transit stops start of massive project for US student
“Permanent traveller” Koudelka returns to Prague with major exhibition
Political scientist: Prague has become a hub for Russian operations in broader Central Europe
Growing concern over plight of leading Chinese investor in the Czech Republic
President Zeman’s Chinese advisor arrested